Axonics Shares Fall Despite Australia's Approval for R20 SNM Device
Express News | Axonics Inc - Expects to Commence Sales of R20 to Australian Customers in November
Express News | Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable Snm System in Australia
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
Deals This Week: Smartsheet, AT&T, BP, Cleveland-Cliffs, Vistra and More
Piper Sandler Maintains Axonics(AXNX.US) With Hold Rating, Maintains Target Price $71
Piper Sandler analyst Adam Maeder maintains $Axonics(AXNX.US)$ with a hold rating, and maintains the target price at $71.According to TipRanks data, the analyst has a success rate of 60.1% and a
Axonics: U.S. Jury Finds Company Doesn't Infringe on Any Three Medtronic Patents-in-Suit >AXNX
Needham Reiterates Hold on Axonics
Axonics Analyst Ratings
Needham Maintains Axonics(AXNX.US) With Hold Rating
Needham analyst Michael Matson maintains $Axonics(AXNX.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 42.9% and a total average return of -5.6% over the past
Hold Rating on Axonics Modulation Technologies Amidst Slowing Growth and Pending Acquisition
RBC Capital Maintains Axonics(AXNX.US) With Hold Rating, Maintains Target Price $71
RBC Capital analyst Shagun Singh Chadha maintains $Axonics(AXNX.US)$ with a hold rating, and maintains the target price at $71.According to TipRanks data, the analyst has a success rate of 43.0% and
RBC Capital Remains a Hold on Axonics Modulation Technologies (AXNX)
Axonics | 10-Q: Q2 2024 Earnings Report
Express News | Axonics Q2 Net Income USD 6.899 Million
Express News | Axonics Q2 Basic EPS USD 0.14
Express News | Axonics Q2 Operating Expenses USD 85.462 Million
Express News | Axonics Q2 Operating Income USD 3.681 Million
Express News | Axonics Q2 Gross Profit USD 89.143 Million
Express News | Axonics Q2 Revenue USD 114.565 Million Vs. IBES Estimate USD 112.7 Million